[PDF] Top 20 Pathogenic role of IL-15 in non-alcoholic fatty liver disease
Has 10000 "Pathogenic role of IL-15 in non-alcoholic fatty liver disease" found on our website. Below are the top 20 most common "Pathogenic role of IL-15 in non-alcoholic fatty liver disease".
Pathogenic role of IL-15 in non-alcoholic fatty liver disease
... examined in detail. IL-2 and IL-15 signalling starts when the cytokines bind IL-2Rα or IL-15Rα, respectively, and are presented to IL-2Rβ and ...presented in trans, by cells expressing IL-15Rα, to ... Voir le document complet
101
Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment
... mapping of body weight and adiposity index identifies diet specific genetic control independent of ...calculated in (129S6xBALB/c) F2mice fed control diet (CHD) (black lines) or high fat diet (HFD) ... Voir le document complet
11
Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context
... utilization of G6P, a common substrate for both lipid and glycogen synthesis, markedly induces these anabolic pathways in ...increase in de novo lipogenesis [11,17,19,21,43] . In addition, our ... Voir le document complet
17
en fr Progression and diagnostic methods in non-alcoholic fatty liver disease Progression et tests diagnostiques de la stéatose hépatique non alcoolique
... level of insulin resistance in patients with steatohep- atitis than in those with isolated steatosis ...changes in weight, lifestyle or glucose or lipid metabolism during follow-up could be ... Voir le document complet
181
Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
... site of PPRE (Santa Cruz ...L of 5X kinase buffer, 1 µ L of T4 polynucleotide kinase (10 U/ µ L), and ...L of TE buffer (10 mmol/L Tris-HCl, pH ...eluted in a Nick column (GE ... Voir le document complet
40
Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role.
... possible pathogenic role of NASH in iCCA. The pathogenic pathway leading from NASH to iCCA is still unclear ...[14]. In the case of NASH-related HCC, intracellular lipid ... Voir le document complet
15
The purinergic p2x7 receptor-nlrp3 inflammasome pathway: A new target in alcoholic liver disease?
... mechanisms of the three stages in ALD: hepatic steatosis, steatohepatitis, and ...patterns. Alcoholic liver steatosis is characterized by the accumulation of lipids in and around ... Voir le document complet
14
Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study
... prevalence of obesity and diabetes mellitus (DM) in humans and mouse disease ...for non-alcoholic fatty liver disease (NAFLD), the most prevalent liver ... Voir le document complet
17
Specificities of Hepatocellular Carcinoma Developed on Non Alcoholic Fatty Liver Disease in Absence of Cirrhosis Revealed by Tissue 1H-NMR Spectroscopy
... Specificities of Hepatocellular Carcinoma Developed in Non Alcoholic Fatty Liver Disease in Absence of Cirrhosis Revealed by Tissue 1 H-NMR Spectroscopy 1 ... Voir le document complet
2
Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials
... impact of probiotics on 15 variables related to obesity, diabetes and ...many of which are inter-related so that concomitant effects would corrobo- rate consistent probiotics ...effect of ... Voir le document complet
13
Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
... source of PPARα ligand [ 260 ]. Interestingly, PPARα-dependent regulation of fatty acid oxidation in extrahepatic tissues plays an important role during fasting and can compensate, at ... Voir le document complet
54
Specificities of Human Hepatocellular Carcinoma Developed on Non-Alcoholic Fatty Liver Disease in Absence of Cirrhosis Revealed by Tissue Extracts 1H-NMR Spectroscopy
... techniques[14,15]. In these studies, both lipid and Figure ...expression of glutamine synthetase (GS): diffuse and intense staining with H-score = 300 (***); focal staining (**) and negative ... Voir le document complet
18
Nutrigenomics of high fat diet induced obesity in mice suggests relationships between susceptibility to fatty liver disease and the proteasome
... roles in the etiology of obesity, type 2 diabetes mellitus and their complications through genotype x environment ...feeding in inbred mouse strains widely used in genetic and physiological ... Voir le document complet
13
Identifying PGC-1α-dependent hepatokines in a non-alcoholic fatty liver disease murine model
... Non-alcoholic fatty liver disease (NAFLD) has become a serious public health problem and is now considered as the major cause of liver disease ...spectrum of ... Voir le document complet
82
Rôle du régulateur du cycle cellulaire p16INK4a dans le développement du diabète de type 2 et dans les maladies métaboliques du foie gras ou NAFLD (Non-Alcoholic Fatty Liver Disease) : rôle de p16INK4a dans le contrôle de la néoglucogenèse hépatique et dans le développement de la stéatose hépatique non alcoolique.
... impact of common genetic variants on complex diseases such as type 2 diabetes and cardiovascular ...artery disease and type 2 diabetes. However, the functional role of the gene products ... Voir le document complet
117
Endoplasmic Reticulum stress signaling and the pathogenesis of Non-Alcoholic Fatty Liver Disease
... target of IRE1α RNase activity, the mRNA encoding the X-box binding protein 1 (XBP1) undergoes unconventional splicing through the concerted action of IRE1α and the tRNA ligase RTCB(15) at a ... Voir le document complet
56
DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease
... deletion of SIRT1 disrupts DEPTOR signaling, promotes mTORC1 activation, and exacerbates the development of alcoholic fatty liver and liver injury in mice Our previous ... Voir le document complet
31
Roles of Ceramides in Non-Alcoholic Fatty Liver Disease
... The role of ceramides is even less clear when exploring mice models invalidated for enzymes of the sphingolipid ...]. In these studies, cathepsins B and D were identi- fied as targets ... Voir le document complet
20
In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal
... organoids; liver-on-a-chip; cell culture 1. Introduction Non-alcoholic fatty liver disease (NAFLD) comprises two histological forms: non- alcoholic fatty ... Voir le document complet
19
Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?
... hepatotoxicity in COVID-19 Although liver injury is not the primary cause of death in COVID-19, elevated serum ALT and AST levels are often observed in hospitalized patients ...cause ... Voir le document complet
32
Sujets connexes